Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer

The androgen receptor (AR) is the main therapeutic target in advanced prostate cancer, because it regulates the growth and progression of prostate cancer cells. Patients may undergo multiple lines of AR-directed treatments, including androgen-deprivation therapy, AR signaling inhibitors (abiraterone...

Descripción completa

Detalles Bibliográficos
Autores principales: Obinata, Daisuke, Lawrence, Mitchell G., Takayama, Kenichi, Choo, Nicholas, Risbridger, Gail P., Takahashi, Satoru, Inoue, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578370/
https://www.ncbi.nlm.nih.gov/pubmed/33134178
http://dx.doi.org/10.3389/fonc.2020.581515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578370/
https://www.ncbi.nlm.nih.gov/pubmed/33134178
http://dx.doi.org/10.3389/fonc.2020.581515

Ejemplares similares